The biological and clinical challenge of liver cancer heterogeneity
- PMID: 30190968
- PMCID: PMC6096446
- DOI: 10.2217/hep.14.18
The biological and clinical challenge of liver cancer heterogeneity
Keywords: cholangiocarcinoma; hepatocellular carcinoma; molecular subtype; precision cancer medicine; tumor genomics heterogeneity.
Conflict of interest statement
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
Figures
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013;63:11–30. - PubMed
-
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. - PubMed
-
- Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002;31:339–346. - PubMed
-
- Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. J. Leukoc. Biol. 2006;80:1197–1213. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources